160 related articles for article (PubMed ID: 25072501)
21. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH; Keeffe EB
J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
[TBL] [Abstract][Full Text] [Related]
22. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
Caruntu FA; Gheorghita V
J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
[No Abstract] [Full Text] [Related]
23. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
Mauss S; Wedemeyer H
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis B Virus Infection: Current Trends and Issues].
Furusyo N; Shimizu M; Ogawa E; Murata M; Hayashi J
Rinsho Byori; 2015 Jun; 63(6):755-61. PubMed ID: 26548241
[TBL] [Abstract][Full Text] [Related]
25. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
[TBL] [Abstract][Full Text] [Related]
26. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
[TBL] [Abstract][Full Text] [Related]
27. Treatment of rheumatic diseases and hepatitis B virus coinfection.
Felis-Giemza A; Olesińska M; Świerkocka K; Więsik-Szewczyk E; Haładyj E
Rheumatol Int; 2015 Mar; 35(3):385-92. PubMed ID: 25549599
[TBL] [Abstract][Full Text] [Related]
28. Direct-acting agents for hepatitis C virus before and after liver transplantation.
Sugawara Y; Hibi T
Biosci Trends; 2018 Jan; 11(6):606-611. PubMed ID: 29238003
[TBL] [Abstract][Full Text] [Related]
29. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
Dervisevic S; Pillay D
J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
[TBL] [Abstract][Full Text] [Related]
30. [Genetic diagnosis of hepatitis B and C].
Gervain J
Orv Hetil; 2003 Dec; 144(52):2547-52. PubMed ID: 15005063
[TBL] [Abstract][Full Text] [Related]
31. What evidence exists to support antiviral treatment in children with chronic hepatitis B?
Iorio R; Tufano M; Giagnorio MG; Spagnuolo MI; Giannattasio A
Antivir Ther; 2014; 19(3):225-7. PubMed ID: 24192644
[TBL] [Abstract][Full Text] [Related]
32. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.
Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF
J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
Katsanos KH; Tsianos VE; Zois CD; Zioga H; Vagias I; Zervou E; Christodoulou DK; Tsianos EV;
J Crohns Colitis; 2010 Oct; 4(4):450-65. PubMed ID: 21122543
[TBL] [Abstract][Full Text] [Related]
34. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
Martin P; Lau DT; Nguyen MH; Janssen HL; Dieterich DT; Peters MG; Jacobson IM
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2071-87.e16. PubMed ID: 26188135
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
[TBL] [Abstract][Full Text] [Related]
36. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
[TBL] [Abstract][Full Text] [Related]
37. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
Chevaliez S; Pawlotsky JM
Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
[TBL] [Abstract][Full Text] [Related]
39. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease.
Mikolajczyk AE; Aronsohn AI
Adv Chronic Kidney Dis; 2015 Sep; 22(5):352-60. PubMed ID: 26311596
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatitis C-related kidney disease.
Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
